KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Free Cash Flow (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Free Cash Flow for 17 consecutive years, with $307.0 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 9.97% to $307.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 49.5% year-over-year, with the annual reading at $1.4 billion for FY2025, 49.5% up from the prior year.
  • Free Cash Flow hit $307.0 million in Q4 2025 for Quest Diagnostics, down from $419.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $645.0 million in Q1 2021 to a low of -$33.0 million in Q1 2023.
  • Historically, Free Cash Flow has averaged $313.8 million across 5 years, with a median of $338.5 million in 2021.
  • Biggest five-year swings in Free Cash Flow: crashed 107.91% in 2023 and later soared 294.0% in 2025.
  • Year by year, Free Cash Flow stood at $337.0 million in 2021, then plummeted by 44.51% to $187.0 million in 2022, then soared by 143.32% to $455.0 million in 2023, then decreased by 25.05% to $341.0 million in 2024, then fell by 9.97% to $307.0 million in 2025.
  • Business Quant data shows Free Cash Flow for DGX at $307.0 million in Q4 2025, $419.0 million in Q3 2025, and $436.0 million in Q2 2025.